Colloidal Iodine Laboratories manufacturing and development company.
In 2012, cancer accounted for 361,000 deaths in Japan by cause of death, and cancer has been the number one cause of death since 1981, with approximately 1 in 2 people getting cancer and 1 in 3 dying from cancer.
This is followed by heart disease (196,000), pneumonia (123,000) and cerebrovascular disease (121,000), with these top four diseases accounting for more than 60% of all deaths. Pneumonia has emerged as one of the top three causes of death since 2011, reflecting the aging population. However, there is still no breakthrough treatment for cancer.
In addition, many people suffer from intractable diseases with unknown causes and no known cure. Colloidal iodine (JCI MN colloidal iodine (C.I.M.N.)) was developed to help many patients suffering from cancer and other incurable diseases.
Approved for medicinal products by the Ministry of Ayurveda, Government of Sri Lanka in 2016
Ayurveda: a 5,000 year old Indian-Sri Lankan tradition of medicine recognized by the World Health Organization (WHO).
Recent Case Reports Using Colloidal Iodine
A Multidisciplinary Approach to Minimally Invasive Cancer Therapy Using Colloidal Iodine: A Case Report of 12 Patients in the Digestive System
Report (English PDF)
Colloid iodine therapy has a wide range of cases and a wide lineup
Outline of JCI colloidal iodine
Colloidal: larger than a molecule, but invisible to an ordinary microscope, particles 10-9 to 10-7 cm in diameter are dispersed in gas, liquid or solid.
The Possibility of Connecting Hope to the Future
Advantages of JCI MN colloidal iodine
It is a colloidal iodine that has been adopted by the largest number of medical institutions in Japan and is used in the largest number of medical institutions.
It has been in clinical practice for more than 10 years and has been used in many cases.
We would like to introduce you to medical institutions that can use JCI MN colloidal iodine
JCI MN colloidal iodine is not sold to the public in Japan.